Manish Dwari

PhD at Max Planck Institute hlr🇩🇪

Masters from NCBS Bangalore🇮🇳

BS-MS graduate from IISER Berhampur🇮🇳 ,

[Heisenberg Lab @HeisenbergCPLab]

Heading to Biomatter: From Cytoskeleton to Embryo in Arolla?
Don’t miss our PhD student Prajwal Patil @Prazzzwa1 at poster #44! Come hear about his cool work on #osmoregulation during #embryogenesis.

#Arolla2025

[Christopher Dooley @CMDooley77]

5/5 🌟 Why It Matters:
First evidence of TA in humans! This work rethinks DMD treatment, showing mRNA decay itself can drive genetic compensation. Kudos to 1st Lara! @DouglasAdamoski @TJ_ThomasJuan & team! @MPI_HLR 🎉 #RareDisease

[Manish Dwari @DwariManish]

Excited to share my Master's research on Collateral Development in the Brain!
https://t.co/TPjlRsO7CN

[Cell Reports @CellReports]

Development of pial collaterals by extension of pre-existing artery tips https://t.co/XIJOHBdnfu

[Soumyashree Das @Soumya3693]

We use live imaging of embryonic mouse brains to describe a new way of making collaterals. Thank you editor, reviewers, all authors and our funders. @India_Alliance @vascularbiology @NCBS_Bangalore @surajk23 @Swarnadipg98 @niolufershan @Vinayak5iv @DwariManish

[Soumyashree Das @Soumya3693]

Pre-print Alert! Intra-vital imaging of embryonic brains reveals pial collateral development by artery tip extension. @NCBS_Bangalore @vascularbiology @surajk23 @niloufershan @Swarnadipg98 @Vinayak5iv @DwariManish
https://t.co/0OPM61nlVb

[IMPRS for Molecular Organ Biology @IMPRS_MOB]

Warm welcome to our IMPRS-MOB Class of 2023! 🤩We wish you a fabulous start to your #PhD journey and we will #support you every step of the way💪🎓 If you want to know more about our program visit https://t.co/PLTyqjggGd

[ATVB: An AHA Journal @atvbahajournals]

New insights into vascular regeneration! @Soumya3693 and team at @NCBS_Bangalore show Artery Cell De-differentiation and Cell Cycle Re-entry upon Cardiac Injury.
https://t.co/1ISoz11BFc
@GauriArolkar @sneha_srivatsa @Karen_MGonzalez @surajk23 @BhavneshBishnoi @PamR33

[Manish Dwari @DwariManish]

@passportsevamea It is been one month of my document verification, I didn't get any notification from bhubaneswar passport office. Neither they are picking up the call, nor , I am able to register for the grievance. Please help me, as I need it urgently.

[IISER Berhampur @IISER_BERHAMPUR]

Hearty Congratulations to Dr. Bhavana Tiwari @iambhavanat for @india_Alliance Intermediate Career Fellowship 2022 in Basic Biomedical Research.

[Gyanaranjan Parida, M.Sc. @i_am_curious742]

In my first year of BSMS(2018), they excluded droppers from INSPIRE, which was totally disheartening. If someone deserves a scholarship based on Merit, then why it was only continued for people taking admission into IISERs( after passing 12th same year).

[Manish Dwari @DwariManish]

@HarishSenapati @i_am_curious742 Are boh apna gyan de raha hai😆

[Jyoti Rathi @JyotiRathi_]

@CSIR_IND you were testing our patience. We quit. You won. Now please release tentative dates "atleast" and start the application process. #csirnet2021 #csirpleaseanswer #conductcsirnet2021
@CSIR_IND @HRDG_CSIR @narendramodi_in @PMOIndia @dpradhanbjp @aajtak @ABPNews @ndtvindia

[Team iGEM IISER Berhampur @iGEM_iiserbpr]

Thrilled to share that we are the winners of the sponsorship challenge!
Thank you, @GenScript! 😁

This will be a big boost to our @iGEM 2021 project. We hope to keep bringing more awareness about Multidrug-Resistant TB and take our project to the next level!

@IISER_BERHAMPUR

[Manish Dwari @DwariManish]

Please help us to fight against MDR TB

[Team iGEM IISER Berhampur @iGEM_iiserbpr]

@GenScript @iGEM In 2018, over 56% of Multidrug-resistant #TB cases were undetected & 64% were untreated in #India.This makes India’s fight against this disease harder, as those with untreated TB can infect others. Read this thread to see how we are bringing awareness to our project's issue:(1/5)

[Team iGEM IISER Berhampur @iGEM_iiserbpr]

@GenScript @iGEM In 2018, over 56% of Multidrug-resistant #TB cases were undetected & 64% were untreated in #India.This makes India’s fight against this disease harder, as those with untreated TB can infect others. Read this thread to see how we are bringing awareness to our project's issue:(1/5)

[Manish Dwari @DwariManish]

@u_is_enough @Chem98Nishad @i_am_curious742 @soujanya_barik @TanishtaBhatta1 @Sudev19332531 @Rohan_Nath_ Yaa, lets do it

[Manish Dwari @DwariManish]

Guys support us

[Team iGEM IISER Berhampur @iGEM_iiserbpr]

@GenScript @iGEM Drug resistance is a major threat to the global health care system. Our team is using #syntheticbiology to create a novel molecular diagnostic kit that will use the CRISPR-Cas technique to detect both Tuberculosis (TB) and Multidrug-resistant TB (MDR-TB). (1/3)

[Team iGEM IISER Berhampur @iGEM_iiserbpr]

@GenScript @iGEM Drug resistance is a major threat to the global health care system. Our team is using #syntheticbiology to create a novel molecular diagnostic kit that will use the CRISPR-Cas technique to detect both Tuberculosis (TB) and Multidrug-resistant TB (MDR-TB). (1/3)

[Manish Dwari @DwariManish]

@i_am_curious742 Multi-Drug Resistance Tuberculosis

[Manish Dwari @DwariManish]

Help us to fight against MDR-TB

[Team iGEM IISER Berhampur @iGEM_iiserbpr]

@GenScript @iGEM TB is the 9th leading cause of deaths all across the world. We aim to develop a cheap, efficient & accessible system for early diagnosis of MDR-TB before it becomes severe or fatal, helping India become TB free by 2025!
What about you? @igem_iisc @iGEMParisSaclay @iGEM_IISERKol